Neoadjuvant Chemoradiation and Duration of Chemotherapy Before Surgical Resection for Pancreatic Cancer: Does Time Interval Between Radiotherapy and Surgery Matter?-Reference-Cited by-同舟云学术

Neoadjuvant Chemoradiation and Duration of Chemotherapy Before Surgical Resection for Pancreatic Cancer: Does Time Interval Between Radiotherapy and Surgery Matter?

Published:2013-11-26 Issue:2 Volume:21 Page:662-669
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Chen Kathryn T.,Devarajan Karthik,Milestone Barton N.,Cooper Harry S.,Denlinger Crystal,Cohen Steven J.,Meyer Joshua E.,Hoffman John P.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1245/s10434-013-3396-5.pdf

Reference30 articles.

1. Habermehl D, Kessel K, Welzel T, Hof H, Abdollahi A, Bergmann F, et al. Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer. Radiat Oncol. 2012;7:28.

2. Chun YS, Milestone BN, Watson JC, Cohen SJ, Burtness B, Engstrom PF, et al. Defining venous involvement in borderline resectable pancreatic cancer. Ann Surg Oncol. 2010;17:2832–8.

3. Yeung RS, Weese JL, Hoffman JP, Solin LJ, Paul AR, Engstrom PF, et al. Neoadjuvant chemoradiation in pancreatic and duodenal carcinoma. A phase II study. Cancer. 1993;72:2124–33.

4. White RR, Hurwitz HI, Morse MA, Lee C, Anscher MS, Paulson EK, et al. Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas. Ann Surg Oncol. 2001;8:758–65.

5. Takai S, Satoi S, Yanagimoto H, Toyokawa H, Takahashi K, Terakawa N, et al. Neoadjuvant chemoradiation in patients with potentially resectable pancreatic cancer. Pancreas. 2008;36:e26–32.

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors associated with favourable pathological tumour response after neoadjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma;HPB;2024-09

2. REDISCOVER guidelines for borderline-resectable and locally advanced pancreatic cancer: management algorithm, unanswered questions, and future perspectives;Updates in Surgery;2024-04-29

3. Does the Addition of Radiation to Neoadjuvant Systemic Therapy Improve Outcomes for Patients with Resected Pancreatic Adenocarcinoma? Analysis of the National Cancer Database;2024-03-04

4. Rethinking the Roles of Cancer-Associated Fibroblasts in Pancreatic Cancer;Cellular and Molecular Gastroenterology and Hepatology;2024

5. Fibrosis following neoadjuvant treatment of PDAC: Less is not always more;The American Journal of Surgery;2023-12